See also this year's filing and all EDGAR filings for this company.
PDF Report 0001533040_2023_Phio_Pharmaceuticals_Corp.pdf
Logs
Graph
Absolute values for 0001533040, Phio Pharmaceuticals Corp.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 12,446,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 183,000 |
| 3 | remainder_Assets | 185,000 |
| 4 | LiabilitiesCurrent | 1,939,000 |
| 5 | LiabilitiesNoncurrent | 35,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,450,000 |
| 9 | ResearchAndDevelopmentExpense | 7,012,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -18,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,814,000 |
| 1 | Liabilities | 1,974,000 |
| 2 | Expenses | 11,462,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 10,840,000 |
| 5 | NetIncome | -11,480,000 |
| 6 | ComprehensiveNetIncome | -11,480,000 |
| 7 | BaseVar | 13,134,000 |
| 8 | EconomicCapitalRatio | 0.969 |
Edgar->Model Mapping
Feature Distribution
Change over Time
